| Home | E-Submission | Sitemap | Editorial Office
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim
Clin Mol Hepatol.2017;23(1):66-73.   Published online February 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0060
                              
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2016;22(4):443-449.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0037
                              
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0019
                              
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol.2016;22(2):241-249.   Published online June 15, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0053
                                 Cited By 1
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
Jeong Han Kim, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2014;20(3):274-282.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.274
                                 Cited By 1
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Clin Mol Hepatol.2014;20(3):267-273.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.267
                                 Cited By 4
Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang
Clin Mol Hepatol.2014;20(2):168-176.   Published online June 30, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.2.168
                                 Cited By 1
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol.2013;19(3):273-279.   Published online September 30, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.3.273
                              
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
Mi Sung Park, Beom Kyung Kim, Kyung Sik Kim, Ja Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Oidov Baartarkhuu, Kwang Hyub Han, Chae Yoon Chon, Sang Hoon Ahn
Clin Mol Hepatol.2013;19(1):29-35.   Published online March 25, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.1.29
                                 Cited By 7
High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B
Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn
Korean J Hepatol.2012;18(1):75-83.   Published online March 22, 2012     
DOI: https://doi.org/10.3350/kjhep.2012.18.1.75
                                 Cited By 10
Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun
Korean J Hepatol.2011;17(4):261-267.   Published online December 26, 2011     
DOI: https://doi.org/10.3350/kjhep.2011.17.4.261
                                 Cited By 3
Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients
Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo
Korean J Hepatol.2009;15(1):52-58.   Published online March 31, 2009     
DOI: https://doi.org/10.3350/kjhep.2009.15.1.52
      
The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with Lamivudine-resistant chronic hepatitis B infection
Jae Hyeon Moon , Mong Cho , Ki Tae Yoon , Jung Ho Bae , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song
Korean J Hepatol.2008;14(4):503-512.   Published online December 31, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.4.503
         Cited By 2
A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with Liver cirrhosis related to hepatitis B virus
Heon Ju Lee , Tae Nyeun Kim , Jong Ryul Eun , Jae Won Choi
Korean J Hepatol.2008;14(3):381-386.   Published online September 30, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.3.381
         Cited By 15
The Korean Journal of Adefovir plus Lamivudine combination therapy in Lamivudine-resistant chronic hepatitis B
So Young Kwon
Korean J Hepatol.2008;14(2):235-239.   Published online June 20, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.2.235
      
Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients
Jin Hee Cho, M.D., Jae Youn Cheong, M.D., Joon Koo Kang, M.D., Jin Sun Park, M.D., Myoung Hee Lee, M.D., Nam Kyu Lim, M.D., Sun Pyo Hong, PhD.1, Soo-Ok Kim, PhD.1, Wang Don Yoo, PhD.1, and Sung Won Cho, M.D.
Korean J Hepatol.2008;14(1):58-66.   Published online March 20, 2008     
DOI: https://doi.org/10.3350/kjhep.2008.14.1.58
         Cited By 1
Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
In Hee Kim , Seong Hun Kim , Hyun Chul Kim , Kyoung Deok Shin , Sang Wook Kim , Seong Ok Lee , Soo Teik Lee , Dae Ghon Kim
Korean J Hepatol.2007;13(3):349-362.   Published online September 20, 2007     
DOI: https://doi.org/10.3350/kjhep.2007.13.3.349
         Cited By 1
Resistance to Adefovir in Patients with Chronic Hepatitis B
Soo Hyung Ryu, M.D.,* Young-Hwa Chung, M.D.
Korean J Hepatol.2006;12(4):484-492.   Published online January 1, 2000
      
Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant
Jeong Ki Kim, M.D.1, Seong Gyu Hwang, M.D.1,2, Hyeuk Park, M.D.1, Hong Youp Choi, M.D.1, Hyo Jin Cho, B.S.2, Kwang Hyun Ko, M.D.1, Sung Pyo Hong, M.D.1, Pil Won Park, M.D.1, Nam Keun Kim, Ph.D.2, and Kyu Sung Rim, M.D.1,2
Korean J Hepatol.2005;11(3):227-242.
      
Efficacy and Safety of Adefovir Dipivoxil in Patients with Decompensated Liver Cirrhosis with Lamivudine Resistance Compared to Patients with Compensated Liver Disease
Won Moon, M.D., Moon Seok Choi, M.D., Yu Mi Moon, R.N., Seung Woon Paik, M.D., Joon Hyoek Lee, M.D., Kwang Cheol Koh, M.D., Byung Chul Yoo, M.D., Jong Chul Rhee, M.D. and Sang Goon Shim, M.D.1
Korean J Hepatol.2005;11(2):125-134.   Published online January 1, 2000
      
Treatment of Chronic Hepatitis B ; Dose and Treatment Duration of Regimen
Young Oh Kweon
Korean J Hepatol.2005;11(1):13-16.   Published online January 1, 2000
      
Treatment of Chronic Hepatitis B ; Indication of Drug Therapy in Patients with Chronic Hepatitis B
Mong Cho
Korean J Hepatol.2005;11(1):1-8.   Published online January 1, 2000
      
1 |
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.